BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
450 results:

  • 1. TSG-6 Inhibits the NF-κB Signaling Pathway and Promotes the Odontogenic Differentiation of Dental Pulp Stem Cells via CD44 in an Inflammatory Environment.
    Wang Y; Xie Y; Xue N; Xu H; Zhang D; Ji N; Chen Q
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540786
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
    Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
    J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
    Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
    Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
    Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. kit ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
    Mühlenberg T; Falkenhorst J; Schulz T; Fletcher BS; Teuber A; Krzeciesa D; Klooster I; Lundberg M; Wilson L; Lategahn J; von Mehren M; Grunewald S; Tüns AI; Wardelmann E; Sicklick JK; Brahmi M; Serrano C; Schildhaus HU; Sievers S; Treckmann J; Heinrich MC; Raut CP; Ou WB; Marino-Enriquez A; George S; Rauh D; Fletcher JA; Bauer S
    J Clin Oncol; 2024 Apr; 42(12):1439-1449. PubMed ID: 38408285
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
    Voissière A; Gomez-Roca C; Chabaud S; Rodriguez C; Nkodia A; Berthet J; Montane L; Bidaux AS; Treilleux I; Eberst L; Terret C; Korakis I; Garin G; Pérol D; Delord JP; Caux C; Dubois B; Ménétrier-Caux C; Bendriss-Vermare N; Cassier PA
    Sci Transl Med; 2024 Jan; 16(731):eadd1834. PubMed ID: 38266104
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circ_0000376 regulates miR-577/HK2/LDHA signaling pathway to promote the growth, invasion and glycolysis of osteosarcoma.
    Dai H; Yi G; Jiang D; Min Y; Li Z
    J Orthop Surg Res; 2024 Jan; 19(1):67. PubMed ID: 38218855
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
    Heinrich MC; Jones RL; George S; Gelderblom H; Schöffski P; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Reichmann W; Sprott K; Achour H; Sherman ML; Ruiz-Soto R; Blay JY; Bauer S
    Nat Med; 2024 Feb; 30(2):498-506. PubMed ID: 38182785
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
    Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
    Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Acute mast cell leukemia without kit D816V mutation and lack of CD2 and CD25-a case report of rare entity.
    Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
    J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models.
    He Y; Li R; She W; Ai Y; Li K; Kumeria T; Jiang Z; Shao Q; Zou C; Albashari AA; Duan X; Ye Q
    J Nanobiotechnology; 2023 Dec; 21(1):488. PubMed ID: 38105218
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT/FOXO1 axis and influences methotrexate resistance in osteosarcoma.
    Luo M; Su Z; Gao H; Tan J; Liao R; Yang J; Lin L
    J Transl Med; 2023 Dec; 21(1):907. PubMed ID: 38087310
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway.
    Huang S; Zhang D; Yi X; Liu C; Jian C; Yu A
    Med Oncol; 2023 Nov; 40(12):353. PubMed ID: 37952032
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miR-3195 suppresses the malignant progression of osteosarcoma cells via targeting SOX4.
    Liang J; Bao D; Ye Z; Cao B; Jin G; Lu Z; Chen J
    J Orthop Surg Res; 2023 Oct; 18(1):809. PubMed ID: 37904207
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
    Wei Z; Xia K; Zheng D; Gong C; Guo W
    Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. (E)-SIS3 suppressed osteosarcoma progression via promoting cell apoptosis, arresting cell cycle, and regulating the tumor immune microenvironment.
    Huang Z; Zhang C; Zhu K; Hu J; Xu E; Ma X; Wang Y; Zhu Y; Zhu J
    Drug Dev Res; 2023 Dec; 84(8):1751-1763. PubMed ID: 37784254
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Circular RNA circBLNK promotes osteosarcoma progression and inhibits ferroptosis in osteosarcoma cells by sponging miR‑188‑3p and regulating GPX4 expression.
    Li Z; Luo Y; Wang C; Han D; Sun W
    Oncol Rep; 2023 Nov; 50(5):. PubMed ID: 37711054
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epitope editing enables targeted immunotherapy of acute myeloid leukaemia.
    Casirati G; Cosentino A; Mucci A; Salah Mahmoud M; Ugarte Zabala I; Zeng J; Ficarro SB; Klatt D; Brendel C; Rambaldi A; Ritz J; Marto JA; Pellin D; Bauer DE; Armstrong SA; Genovese P
    Nature; 2023 Sep; 621(7978):404-414. PubMed ID: 37648862
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Preclinical evaluation and pilot clinical study of [
    Ma X; Zhou X; Hu B; Li X; Yao M; Li L; Qin X; Li D; Yao Y; Hou X; Liu S; Chen Y; Wang Z; Zhou W; Li N; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3838-3850. PubMed ID: 37555904
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.